Search Results - "Klemm, Lars"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia by Park, Eugene, Gang, Eun Ji, Hsieh, Yao-Te, Schaefer, Paul, Chae, Sanna, Klemm, Lars, Huantes, Sandra, Loh, Mignon, Conway, Edward M., Kang, Eun-Suk, Hoe Koo, Hong, Hofmann, Wolf-Karsten, Heisterkamp, Nora, Pelus, Louis, Keerthivasan, Ganesan, Crispino, John, Kahn, Michael, Müschen, Markus, Kim, Yong-Mi

    Published in Blood (25-08-2011)
    “…Relapse of drug-resistant acute lymphoblastic leukemia (ALL) has been associated with increased expression of survivin/BIRC5, an inhibitor of apoptosis…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    CD25 Enables Oncogenic BCR Signaling and Represents a Therapeutic Target in Refractory B Cell Malignancies by Lee, Jae-Woong, Geng, Huimin, Chen, Zhengshan, Klemm, Lars, Cosgun, Kadriye Nehir, Xiao, Gang, Masouleh, Behzad, Hurtz, Christian, Parekh, Samir, Kornblau, Steven M., Melnick, Ari, Abbas, Abul, Paietta, Elisabeth, Müschen, Markus

    Published in Blood (02-12-2016)
    “…Background and hypothesis: B cells critically depend on continuous survival and proliferation signals from a functional B cell receptor (BCR). In >50% of B…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine by Tsai, Chiou-Tsun, Yang, Pei-Ming, Chern, Ting-Rong, Chuang, Shu-Hui, Lin, Jung-Hsin, Klemm, Lars, Müschen, Markus, Chen, Ching-Chow

    Published in Oncotarget (15-01-2014)
    “…Activation-induced cytidine deaminase (AID) was originally identified as an inducer of somatic hypermutation (SHM) and class switch recombination (CSR) in…”
    Get full text
    Journal Article
  13. 13

    Separation of B- and T-Cell-Specific Signaling Molecules Prevents Oncogenic Transformation in Lymphoid Malignancies by Ketzer, Franz, Klemm, Lars, Robinson, Mark E, Loucks, Christian, Arce, David Fonseca, Cosgun, Kadriye Nehir, Kothari, Shalin, Müschen, Markus

    Published in Blood (02-11-2023)
    “…Background and significance: Despite the highly homologous structure and function of proteins controlling signal transduction from the BCR and TCR, B- and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Genetic Knockin Approaches to Reconstructing DLBCL-Subtypes from Human Germinal Center B-Cells by Khanduja, Dhruv, Robinson, Mark E, Arce, David Fonseca, Klemm, Lars, Leveille, Etienne, Kothari, Shalin, Caeser, Rebecca, Hodson, Daniel James, Müschen, Markus

    Published in Blood (02-11-2023)
    “…Background and Significance: The clinical and genetic heterogeneity of DLBCL has led to the recent classification of the disease into five genetically distinct…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Dependence of lymphopoiesis on efficient β-catenin degradation by Cosgun, Kadriye, Jumaa, Huda, Robinson, Mark, Klemm, Lars, Oulghazi, Salim, Fonseca-Arce, David, Xu, Liang, Xiao, Gang, Khanduja, Dhruv, Chan, Lai, Lee, Jaewoong, Kume, Kohei, Song, Joo, Chan, Wing-Chung, Chen, Jianjun, Taketo, Mark, Kothari, Shalin

    Published in The Journal of immunology (1950) (01-05-2024)
    “…Abstract Wnt/β-catenin pathway is tightly controlled by β-catenin destruction complex to regulate lineage specification and differentiation. Compared to…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Targeting Unique Synthetic Lethal Interactions between PI3K and MYC in B-ALL by Xiao, Gang, Kume, Kohei, Geng, Huimin, Han, Than Than, Klemm, Lars, Müschen, Markus

    Published in Blood (13-11-2019)
    “…Significance: Activating mutations of PIK3CA and other PI3K subunits are frequent in almost all types of cancer. Likewise, inactivating lesions of PTEN are…”
    Get full text
    Journal Article
  20. 20